Alternatīvu asins pārliešanas paņēmienu izmaksu lietderība
Ortopēdiskā ķirurģija
Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (opens new window)
Avots: J Bone Joint Surg Am 2013;95(21):1969-74.
Raksts indeksēts: PubMed 24196467
DOI: 10.2106/JBJS.L.00908
https://www.ncbi.nlm.nih.gov/pubmed/24196467 (opens new window)
Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (opens new window)
Avots: J Bone Joint Surg Am 2013;95(21):1961-8.
Raksts indeksēts: PubMed 24196466
DOI: 10.2106/JBJS.L.00907
https://www.ncbi.nlm.nih.gov/pubmed/24196466 (opens new window)
Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (opens new window)
Avots: Ann Surg 2019;269(5):794-804.
Raksts indeksēts: PubMed 30418206
DOI: 10.1097/SLA.0000000000003095
https://www.ncbi.nlm.nih.gov/pubmed/30418206 (opens new window)
Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (opens new window)
Avots: Spine 2009;34(19):2096-103.
Raksts indeksēts: PubMed 19730217
DOI: 10.1097/BRS.0b013e3181b1fab2
https://www.ncbi.nlm.nih.gov/pubmed/19730217 (opens new window)
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. (opens new window)
Avots: J Orthop Surg 2017;25(1):2309499016684725.
Raksts indeksēts: PubMed 28176599
DOI: 10.1177/2309499016684725
https://www.ncbi.nlm.nih.gov/pubmed/28176599 (opens new window)
An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (opens new window)
Avots: J Arthroplasty 2013;28(8 Suppl):74-7.
Raksts indeksēts: PubMed 24034510
DOI: 10.1016/j.arth.2013.06.037
https://www.ncbi.nlm.nih.gov/pubmed/24034510 (opens new window)
Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (opens new window)
Avots: J Bone Joint Surg Am 2012;94(21):1952-8.
Raksts indeksēts: PubMed 23138237
DOI: 10.2106/JBJS.K.00632
https://www.ncbi.nlm.nih.gov/pubmed/23138237 (opens new window)
Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (opens new window)
Avots: J Knee Surg 2017;30(5):460-6.
Raksts indeksēts: PubMed 27699724
DOI: 10.1055/s-0036-1593362
https://www.ncbi.nlm.nih.gov/pubmed/27699724 (opens new window)
Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (opens new window)
Avots: J Arthroplasty 2017;32(8):2375-80.
Raksts indeksēts: PubMed 28343823
DOI: 10.1016/j.arth.2017.02.068
https://www.ncbi.nlm.nih.gov/pubmed/28343823 (opens new window)
Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. (opens new window)
Avots: Am J Orthop 2016;45(7):E439-43.
Raksts indeksēts: PubMed 28005108
https://www.ncbi.nlm.nih.gov/pubmed/28005108 (opens new window)
Clinical and cost effectiveness-related aspects of retransfusion in total hip and knee arthroplasty. (opens new window)
Avots: Ortop Traumatol Rehabil 2012;14(5):421-8.
Raksts indeksēts: PubMed 23208933
DOI: 10.5604/15093492.1016367
https://www.ncbi.nlm.nih.gov/pubmed/23208933 (opens new window)
The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (opens new window)
Avots: Spine J 2017;17(7):977-82.
Raksts indeksēts: PubMed 28323241
DOI: 10.1016/j.spinee.2017.03.004
https://www.ncbi.nlm.nih.gov/pubmed/28323241 (opens new window)
Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (opens new window)
Avots: Orthop Clin North Am 2017;48(2):109-15.
Raksts indeksēts: PubMed 28336035
DOI: 10.1016/j.ocl.2016.12.001
https://www.ncbi.nlm.nih.gov/pubmed/28336035 (opens new window)
Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (opens new window)
Avots: Ir Med J 2018;111(4):730.
Raksts indeksēts: PubMed 30465599
https://www.ncbi.nlm.nih.gov/pubmed/30465599 (opens new window)
Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (opens new window)
Avots: Anesth Analg 2022;135(3):576-85.
Raksts indeksēts: PubMed 35977366
DOI: 10.1213/ANE.0000000000006114
https://www.ncbi.nlm.nih.gov/pubmed/35977366 (opens new window)
Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study. (opens new window)
Avots: J Orthop Surg Res 2014;9:50.
Raksts indeksēts: PubMed 24997589
DOI: 10.1186/s13018-014-0050-2
https://www.ncbi.nlm.nih.gov/pubmed/24997589 (opens new window)
Tranexamic acid decreases blood loss after total shoulder arthroplasty. (opens new window)
Avots: J Shoulder Elbow Surg 2016;25(4):614-8.
Raksts indeksēts: PubMed 26652697
DOI: 10.1016/j.jse.2015.09.014
https://www.ncbi.nlm.nih.gov/pubmed/26652697 (opens new window)
Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (opens new window)
Avots: Transfusion 2017;57(2):357-66.
Raksts indeksēts: PubMed 28019009
DOI: 10.1111/trf.13936
https://www.ncbi.nlm.nih.gov/pubmed/28019009 (opens new window)
Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. (opens new window)
Avots: J Arthroplasty 2013;28(8 Suppl):137-9.
Raksts indeksēts: PubMed 23886409
DOI: 10.1016/j.arth.2013.04.054
https://www.ncbi.nlm.nih.gov/pubmed/23886409 (opens new window)
Cell saver for adult spinal deformity surgery reduces cost. (opens new window)
Avots: Spine Deform 2017;5(4):272-6.
Raksts indeksēts: PubMed 28622903
DOI: 10.1016/j.jspd.2017.01.005
https://www.ncbi.nlm.nih.gov/pubmed/28622903 (opens new window)
Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (opens new window)
Avots: J Am Acad Orthop Surg 2021;29(22):961-9.
Raksts indeksēts: PubMed 34570739
DOI: 10.5435/JAAOS-D-20-00971
https://www.ncbi.nlm.nih.gov/pubmed/34570739 (opens new window)
Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (opens new window)
Avots: Orthopedics 2017;40(6):e1044-9.
Raksts indeksēts: PubMed 28968480
DOI: 10.3928/01477447-20170925-07
https://www.ncbi.nlm.nih.gov/pubmed/28968480 (opens new window)
Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. (opens new window)
Avots: J Arthroplasty 2015;30(2):192-5.
Raksts indeksēts: PubMed 25534861
DOI: 10.1016/j.arth.2014.08.020
https://www.ncbi.nlm.nih.gov/pubmed/25534861 (opens new window)
Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (opens new window)
Avots: Orthop Traumatol Surg Res 2012;98(5):477-83.
Raksts indeksēts: PubMed 22854336
DOI: 10.1016/j.otsr.2012.05.002
https://www.ncbi.nlm.nih.gov/pubmed/22854336 (opens new window)
Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial. (opens new window)
Avots: Bone Jt Open 2022;3(7):536-42.
Raksts indeksēts: PubMed 35816170
DOI: 10.1302/2633-1462.37.BJO-2021-0213.R1
https://www.ncbi.nlm.nih.gov/pubmed/35816170 (opens new window)
Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. (opens new window)
Avots: Br J Anaesth 2012;108(6):943-52.
Raksts indeksēts: PubMed 22593128
DOI: 10.1093/bja/aes135
https://www.ncbi.nlm.nih.gov/pubmed/22593128 (opens new window)
Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (opens new window)
Avots: Transfusion 2017;57(6):1347-58.
Raksts indeksēts: PubMed 28150313
DOI: 10.1111/trf.14006
https://www.ncbi.nlm.nih.gov/pubmed/28150313 (opens new window)
Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. (opens new window)
Avots: Br J Anaesth 2007;99(6):794-800.
Raksts indeksēts: PubMed 17928302
DOI: 10.1093/bja/aem266
https://www.ncbi.nlm.nih.gov/pubmed/17928302 (opens new window)
A safe, simple and cost-effective protocol for blood transfusion in primary total knee replacement. (opens new window)
Avots: Ann R Coll Surg Engl 2004;86(4):260-2.
Raksts indeksēts: PubMed 15239867
DOI: 10.1308/147870804551
https://www.ncbi.nlm.nih.gov/pubmed/15239867 (opens new window)
Are allogeneic transfusions decreasing in total knee arthroplasty patients? National Inpatient Sample 2009-2013. (opens new window)
Avots: J Arthroplasty 2018;33(6):1705-12.
Raksts indeksēts: PubMed 29352682
DOI: 10.1016/j.arth.2017.12.014
https://www.ncbi.nlm.nih.gov/pubmed/29352682 (opens new window)
Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (opens new window)
Avots: J Arthroplasty 2015;30(3):365-8.
Raksts indeksēts: PubMed 25458093
DOI: 10.1016/j.arth.2014.10.008
https://www.ncbi.nlm.nih.gov/pubmed/25458093 (opens new window)
The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. (opens new window)
Avots: Blood Transfus 2013;11(2):260-71.
Raksts indeksēts: PubMed 23149145
DOI: 10.2450/2012.0139-12
https://www.ncbi.nlm.nih.gov/pubmed/23149145 (opens new window)
Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (opens new window)
Avots: Blood Transfus 2014;12(1):40-9.
Raksts indeksēts: PubMed 24120595
DOI: 10.2450/2013.0088-13
https://www.ncbi.nlm.nih.gov/pubmed/24120595 (opens new window)
Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. (opens new window)
Avots: Transfusion 2011;51(1):118-24.
Raksts indeksēts: PubMed 20624257
DOI: 10.1111/j.1537-2995.2010.02783.x
https://www.ncbi.nlm.nih.gov/pubmed/20624257 (opens new window)
Comparative risk of transfusion and incremental total hospitalization cost for primary unilateral, bilateral, and revision total knee arthroplasty procedures. (opens new window)
Avots: J Arthroplasty 2016;31(3):583-589.e1.
Raksts indeksēts: PubMed 26699673
DOI: 10.1016/j.arth.2015.10.013
https://www.ncbi.nlm.nih.gov/pubmed/26699673 (opens new window)
The efficacy, safety, and cost-effectives of combined administration of intravenous and local tranexamic acid in the management of patients undergoing primary total hip arthroplasty: a prospective, blinded and randomized clinical study. (opens new window)
Avots: Acta Orthop Traumatol Turc 2021;55(5):422-7.
Raksts indeksēts: PubMed 34730529
DOI: 10.5152/j.aott.2021.20397
https://www.ncbi.nlm.nih.gov/pubmed/34730529 (opens new window)
Blood loss control with two doses of tranexamic acid in a multimodal protocol for total knee arthroplasty. (opens new window)
Avots: Open Orthop J 2011;5:44-8.
Raksts indeksēts: PubMed 21552468
DOI: 10.2174/1874325001105010044
https://www.ncbi.nlm.nih.gov/pubmed/21552468 (opens new window)
ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. (opens new window)
Avots: Anesth Analg 2022;135(3):448-58.
Raksts indeksēts: PubMed 35977355
DOI: 10.1213/ANE.0000000000006065
https://www.ncbi.nlm.nih.gov/pubmed/35977355 (opens new window)
Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (opens new window)
Avots: J Arthroplasty 2016;31(3):579-82.
Raksts indeksēts: PubMed 26601635
DOI: 10.1016/j.arth.2015.10.001
https://www.ncbi.nlm.nih.gov/pubmed/26601635 (opens new window)
Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. (opens new window)
Avots: Transfusion 2016;56(2):466-71.
Raksts indeksēts: PubMed 26509250
DOI: 10.1111/trf.13354
https://www.ncbi.nlm.nih.gov/pubmed/26509250 (opens new window)
Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. (opens new window)
Avots: BMJ 2014;349:g4829.
Raksts indeksēts: PubMed 25116268
DOI: 10.1136/bmj.g4829
https://www.ncbi.nlm.nih.gov/pubmed/25116268 (opens new window)
One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (opens new window)
Avots: Clin Orthop Relat Res 2010;468(7):1905-11.
Raksts indeksēts: PubMed 20063079
DOI: 10.1007/s11999-009-1217-8
https://www.ncbi.nlm.nih.gov/pubmed/20063079 (opens new window)
Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (opens new window)
Avots: J Arthroplasty 2018;33(7):2092-9.e9.
Raksts indeksēts: PubMed 29605152
DOI: 10.1016/j.arth.2018.02.068
https://www.ncbi.nlm.nih.gov/pubmed/29605152 (opens new window)
Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. (opens new window)
Avots: Transfus Med 2009;19(4):202-6.
Raksts indeksēts: PubMed 19706137
DOI: 10.1111/j.1365-3148.2009.00929.x
https://www.ncbi.nlm.nih.gov/pubmed/19706137 (opens new window)
Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. (opens new window)
Avots: Int Orthop 2019;43(1):39-46.
Raksts indeksēts: PubMed 30232527
DOI: 10.1007/s00264-018-4149-7
https://www.ncbi.nlm.nih.gov/pubmed/30232527 (opens new window)
Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (opens new window)
Avots: Int Orthop 2019;43(12):2707-14.
Raksts indeksēts: PubMed 30671601
DOI: 10.1007/s00264-019-04291-4
https://www.ncbi.nlm.nih.gov/pubmed/30671601 (opens new window)
Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. (opens new window)
Avots: J Orthop Surg Res 2011;6:22.
Raksts indeksēts: PubMed 21600028
DOI: 10.1186/1749-799X-6-22
https://www.ncbi.nlm.nih.gov/pubmed/21600028 (opens new window)
Increased hospital costs associated with red blood cell transfusion. (opens new window)
Avots: Transfusion 2015;55(5):1082-9.
Raksts indeksēts: PubMed 25488623
DOI: 10.1111/trf.12958
https://www.ncbi.nlm.nih.gov/pubmed/25488623 (opens new window)
Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (opens new window)
Avots: J Arthroplasty 2014;29(8):1512-5.
Raksts indeksēts: PubMed 24630599
DOI: 10.1016/j.arth.2014.01.031
https://www.ncbi.nlm.nih.gov/pubmed/24630599 (opens new window)
Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (opens new window)
Avots: J Arthroplasty 2020;35(11):3084-8.
Raksts indeksēts: PubMed 32654943
DOI: 10.1016/j.arth.2020.06.018
https://www.ncbi.nlm.nih.gov/pubmed/32654943 (opens new window)
Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial. (opens new window)
Avots: Thromb Res 2018;171:143-8.
Raksts indeksēts: PubMed 30312799
DOI: 10.1016/j.thromres.2018.10.006
https://www.ncbi.nlm.nih.gov/pubmed/30312799 (opens new window)
Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. (opens new window)
Avots: BMC Health Serv Res 2013;13:186.
Raksts indeksēts: PubMed 23692862
DOI: 10.1186/1472-6963-13-186
https://www.ncbi.nlm.nih.gov/pubmed/23692862 (opens new window)
The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. (opens new window)
Avots: Int Orthop 2007;31(3):303-8.
Raksts indeksēts: PubMed 16810542
DOI: 10.1007/s00264-006-0173-0
https://www.ncbi.nlm.nih.gov/pubmed/16810542 (opens new window)
Efficacy and safety of tranexamic acid in total hip replacement: a PRISMA-compliant meta-analysis of 25 randomized controlled trials. (opens new window)
Avots: Medicine 2017;96(52):e9552.
Raksts indeksēts: PubMed 29384974
DOI: 10.1097/MD.0000000000009552
https://www.ncbi.nlm.nih.gov/pubmed/29384974 (opens new window)